Upstream Bio, Inc. · NASDAQ:UPB
Decheng Capital Global Life Sciences Fund IV, L.P. reported a 5.00% stake in Upstream Bio, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Decheng Capital Global Life Sciences Fund IV, L.P. reported a 5.00% stake in Upstream Bio, Inc., 2,724,868 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.00%
- Shares
- 2,724,868
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 5.00% | 2,724,868 |
| Decheng Capital Management IV (Cayman), LLC | 5.00% | 2,724,868 |
| Decheng Capital Global Healthcare Fund (Master), LP | 0% | 0 |
| Decheng Capital Global Healthcare GP, LLC | 0% | 0 |
| Xiangmin Cui | 5.00% | 2,724,868 |
Source
Related
- Upstream Bio, Inc.
- Decheng Capital Global Life Sciences Fund IV, L.P.
- Upstream Bio, Inc. shareholders
- Schedule 13G · Decheng Capital Global Life Sciences Fund IV, L.P. · Feb 14, 2025
- Form 4 · Deykin Aaron · Sep 17, 2026
- Form 4 · Sutherland Everett Rand · Sep 17, 2026
- Form 4 · Houghton Adam · Sep 17, 2026
- Form 4 · Gray Michael · Sep 17, 2026
- Form 4 · Ambrose Allison · Sep 17, 2026